Best printers for Home

Best Mixer Grinder

Best wired Earphones

Best 43 Inch TV in India

Best Wi Fi Routers

Best Home Theatre in India

Smart Watch under 5000

Best Laptops for Education

Best Laptop for Students

<ul><li>Insurtech company <keyword id="7772673" type="General" weightage="100" keywordseo="insurancedekho" source="Orion">InsuranceDekho</keyword> on Tuesday said it has raised $150 million in its Series A funding.</li><li>Funding was led by Goldman Sachs Asset Management and <keyword id="267061" type="General" weightage="50" keywordseo="tvs-capital-funds" source="Orion">TVS Capital Funds</keyword>.</li></ul>Insurtech company InsuranceDekho on Tuesday said it has raised $150 million in its Series A funding, led by Goldman Sachs Asset Management and TVS Capital Funds. Touted as the largest-ever series A round by an Indian insurtech company, the fresh funding, a mix of equity and debt, also saw participation from Investcorp, Avataar Ventures and <keyword id="763894" type="General" weightage="50" keywordseo="leapfrog-investments" source="Orion">LeapFrog Investments</keyword>. "The fundraising will enable us to deploy scalable Insurtech solutions in the areas of data analytics, artificial intelligence, last mile servicing and claims management while keeping customer experience at the core of everything," said <keyword id="16520994" type="General" weightage="50" keywordseo="ish-babbar" source="Orion">Ish Babbar</keyword>, Co-founder and CTO, InsuranceDekho. The company said that it will use the funds to scale up its product and technology functions, expand to new markets, and launch new products in the health and life categories. InsuranceDekho was launched by automobile aggregator CarDekho in 2016. During FY22, InsuranceDekho's revenue surged 61 per cent to Rs 47.91 crore from Rs 29.71 crore in FY21. The company aims to achieve an annualised premium run rate of Rs 3,500 crore by March 2023. "InsuranceDekho has demonstrated a proven ability to bring new-to-insurance channel partners to their platform while empowering them through technology-based solutions and working closely with insurers," said <keyword id="1548602" type="General" weightage="50" keywordseo="rajat-sood" source="Orion">Rajat Sood</keyword>, managing director at Goldman Sachs Asset Management. InsuranceDekho is present in more than 1,300 towns covering 98 per cent of pin codes in the country. SEE ALSO: <a href="https://www.businessinsider.in/entertainment/news/how-to-protect-yourself-from-dating-app-fraud-scam/articleshow/97773479.cms">Love is in the air, but so are scammers: Protect yourself from valentines day dating app frauds</a> <a href="https://www.businessinsider.in/tech/news/google-unleashes-ai-powered-updates-to-revamp-user-experience-on-maps-search-and-translate/articleshow/97761551.cms">Google unleashes AI-powered updates to revamp user experience on Maps, Search and Translate</a>

InsuranceDekho raises $150 mn, largest-ever Series A funding by an insuretech startup

New Delhi, Dec 12 () Agritech startup Ecozen on Thursday said it has raised USD 6 million (around Rs 42 crore) from investors to fund its expansion plan.
Based in Pune, Ecozen was founded by three IIT Kharagpur alumni, Devendra Gupta, Prateek Singhal and Vivek Pandey. It develops technology-enabled products to strengthen farm-to-fork value chain of perishables.
Ecozen said in a statement it has completed its USD 6 million Series A fund raise, after receiving investment from Sathguru Catalyser's Innovation in Food &amp; Agriculture Fund (IFA Fund). This funding is on top of the investment received in July 2019 from Caspian and the Hivos-Triodos Fund".
Omnivore, which originally invested in Ecozen in 2015, also participated in this round.
The company had raised USD 3 million in seed funding.
Ecozen's irrigation and cold chain products (Ecotron and Ecofrost) help farmers who grow perishables to increase their yields, store their produce longer, and realise higher prices. The company said that about 25,000 farmers in India use its products.
A Krishna Kumar, ex-MD of State Bank of India, will be joining Ecozen's board as the company embarks on its next phase of growth, the statement said.
Ecozen Co-Founder &amp; CEO Devendra Gupta said: "The funding raised will enable us to expand our product range, production capacity, and enter new geographies".
Vijayaraghavan Kannan, Senior Partner at IFA Fund said: "Ecozen has focused on using technology as a differentiator and has pioneered innovative products addressing market imperfections and catering to underserved segments of agriculture &amp; food value chain".
Ravi Narasimham, Investment Director at Caspian, said, "...we believe this round of funding will help Ecozen realize its potential by furthering its business strategy across new geographies by launching its innovative product range". MJH BAL

Agri-tech startup Ecozen raises USD 6mn in Series A funding

<ul><li><keyword id="8164702" type="General" weightage="100" keywordseo="twid" source="Orion">Twid</keyword>, a payment solution platform, has raised $12 million in a series A funding round led by Rakuten Capital.</li><li>The round also saw participation from <keyword id="6355629" type="General" weightage="20" keywordseo="google" source="Orion">Google</keyword>, ICMG Partners, JAFCO Asia, January Capital and many more.</li><li>The company will use the funds to build its merchant and issuer network and hire new talent.</li></ul>Bangalore-based payment solutions platform Twid on Wednesday said it had secured $12 million in a series-A funding round that was led by Rakuten Capital and also had Google Investing. The round also saw participation from ICMG Partners, JAFCO Asia, January Capital and Reddy Futures Fund along with existing investors BEENEXT and <keyword id="563136" type="General" weightage="20" keywordseo="Sequoia-India" source="Orion">Sequoia India</keyword>'s Surge. The company intends to use the funds to scale up and build its merchant and issuer network, expand product roll-outs, build tech capabilities – primarily in data science, and hire new talent. With this funding round, <keyword id="4385887" type="General" weightage="20" keywordseo="Rakuten-India" source="Orion">Rakuten India</keyword> CEO Sunil Gopinath will join Twid’s board of directors on behalf of Rakuten Capital – Rakuten Group’s corporate venture capital arm. “Twid is on a mission to revolutionise how rewards are viewed, understood and used across platforms by creating a completely new network. We are bringing together various industry stakeholders, nudging them towards a cashless ecosystem and future,” said <keyword id="2939430" type="General" weightage="20" keywordseo="Amit-Koshal" source="Orion">Amit Koshal</keyword>, co-founder and CEO of Twid. Founded in 2020 by Koshal, Rishi Batra, and Amit Sharma, Twid provides a platform that combines multiple loyalty/reward points of users across issuers such as banks, fintech firms, retail or e-commerce brands, and allows consumers to pay at offline and online stores using their reward points. According to the Q1 2022 Global Loyalty Programs survey, the loyalty programmes market in India is expected to grow by 12.6% on an annual basis to reach almost $143 billion in 2022. In India, loyalty and reward programmes have been used by brands and organizations – especially in the hospitality, tourism, aviation and retail sectors – as a strategy to broaden and deepen their customer base . Twid claims to have over 40 million registered users, and over 50,000 live merchants. It also has a payment network of banks, brands, payment gateways, merchants and customers. “By enabling reward points to be ubiquitous and fungible, we are witnessing very high customer delight. Customers are able to stay updated with their points and are able to save, earn and pay every time when using ‘Pay with Rewards’. This reaffirms our approach to delivering long-term value to merchants, issuers and customers,” Koshal added. ‘Pay with rewards’ is Twid’s payment option that enables buyers to use their reward points as payment at the time of purchase. SEE ALSO: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/business/corporates/news/adani-transmission-is-now-the-12th-biggest-listed-entity-other-adani-cos-are-not-far-away/slidelist/93317527.cms">Adani Transmission is now the 12th biggest listed entity; other Adani cos are not far away</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/india/news/inflation-weather-and-more-push-july-services-sector-growth-to-a-4-month-low/articleshow/93315248.cms">Inflation, weather and more push July services sector growth to a 4-month low</a>

Payment solutions company Twid raises $12 million in series A funding from Rakuten Capital, Google and others

<keyword id="744121" type="PERSON" weightage="20" keywordseo="minimalist">Minimalist</keyword>, a new-age homegrown <keyword id="2782303" type="PERSON" weightage="20" keywordseo="skincare-brand">skincare brand</keyword>, has raised Series A funding of Rs <keyword id="73571" type="PERSON" weightage="20" keywordseo="110-crore">110 crore</keyword> through multiple international investors in just nine months of its inception. The round was led by <keyword id="136147" type="COMPANY" weightage="20" keywordseo="Sequoia-Capital-India">Sequoia Capital India</keyword>, with participation from <keyword id="2919607" type="ORGANIZATION" weightage="20" keywordseo="Unilever-Ventures">Unilever Ventures</keyword>. The brand plans to utilise the funds to enhance its infrastructure and R&amp;D capabilities, launch in global markets, as well as double down on its content creation efforts by sharing well-researched knowledge about skincare with its consumers. Launched in 2020 by Mohit and Rahul Yadav, Minimalist, which is a mission-driven brand committed to bringing high-levels of efficacy and transparency to the personal care segment, is rapidly gaining popularity due to its values and ethos. So far, they have served over one million customers and is the fastest growing skincare brand in India. Their products are popular among both women and men looking for solutions to acne, pigmentation, excess sebum, dull skin. Speaking about the fundraise, Mohit Yadav, Co-founder - Minimalist, said, "Consumers today are looking beyond marketing claims and are seeking efficacy based skincare products. Our growth so far proves that a radical change in skincare industry is underway. Together with our customers, we are creating 'Skincare 2.0' by offering proven solutions driven by scientific innovations." Having a portfolio of diverse skincare and hair care products, the brand retails through its own website, along with e-commerce giants like Amazon, Nykaa, Flipkart, Myntra, and numerous other marketplaces. Minimalist currently offers 20 products ranging from serums, toners, face acids and moisturizers that are well researched, backed by proven science, safe, effective, mindfully created, and suited for all skin types. "Minimalist's products take an efficacy-first approach using transparency and science as underpinnings to improving personal care outcomes. This has resulted in a strong following and business momentum. Having seen the power of Mohit and Rahul's execution over many years, <keyword id="122716" type="CITY" weightage="20" keywordseo="Sequoia-Capital">Sequoia Capital</keyword> India is thrilled to lead the Series A financing in the company," said Shailesh Lakhani, Managing Director, <keyword id="563136" type="ORGANIZATION" weightage="20" keywordseo="Sequoia-India">Sequoia India</keyword>. "Minimalist is trailblazing science-backed clean beauty formulations in India, a trend that has gained massive consumer acceptance worldwide and with growing consumer traction in India. We look forward to working with the founders and management team along with our fellow investors in supporting the brand's ambitions over the coming years," said Pawan Chaturvedi, Partner at Unilever Ventures. Sequoia Capital India operates in India and Southeast Asia, where they actively partner with founders across sectors from idea to IPO. Unilever Ventures is the venture capital arm of British multinational consumer goods company <keyword id="261686" type="COMPANY" weightage="20" keywordseo="Unilever-plc">Unilever PLC</keyword> that invests in fast growing companies across consumer and enterprise technology. SEE ALSO <a href="https://www.businessinsider.in/business/news/byjus-last-two-acquisitions-and-a-deal-with-disney-reveal-its-american-dream/articleshow/84783749.cms">Byju's last two acquisitions and a deal with Disney reveal its American dream ⁠— one that is anchored in India</a> <a href="https://www.businessinsider.in/personal-finance/news/six-red-flags-for-investors-to-avoid-becoming-a-victim-of-misselling-by-agents-or-financial-advisors/slidelist/84782913.cms">Six red flags for investors to avoid becoming a victim of misselling by agents or financial advisors</a>

Skincare brand Minimalist raises ₹110 crore in Series A funding led by Sequoia Capital India

It is said that every newborn faces a potential risk until the baby has been screened for <keyword id="1144427" type="UNKNOWN" weightage="100" keywordseo="medical-conditions">medical conditions</keyword>. A <keyword id="2024251" type="UNKNOWN" weightage="100" keywordseo="Genetic-screening">genetic screening</keyword> of the newborn means enhanced <keyword id="2024262" type="UNKNOWN" weightage="100" keywordseo="Biotechnological-capacity">biotechnological capacity</keyword>, which ensures fast, accurate and expanded testing going beyond routine disorders. <keyword id="2024252" type="UNKNOWN" weightage="100" keywordseo="Newborn-screening">Newborn screening</keyword> (<keyword id="116258" type="ORGANIZATION" weightage="100" keywordseo="NBS">NBS</keyword>) has been made compulsory in 52 countries across the world, bringing down <keyword id="153995" type="UNKNOWN" weightage="100" keywordseo="infant-mortality">infant mortality</keyword> and disabilities in children. 
 Simply put, newborn screening (NBS) programme includes testing every newborn soon after its birth, to identify serious or life-threatening conditions which may lead to mental/physical retardation or even early death. The affected baby looks healthy at birth as there is no external defect and these disorders cannot be diagnosed until specifically tested for. However, India is yet to implement a <keyword id="2024264" type="UNKNOWN" weightage="100" keywordseo="National-newborn-screening-programme">national newborn screening programme</keyword> even though 5-15% of newborns fall prey to <keyword id="120871" type="UNKNOWN" weightage="100" keywordseo="Metabolic-disorders">metabolic disorders</keyword>. 
 Understandably, not too many Indian start-ups operate in the NBS space and the <keyword id="49685" type="UNKNOWN" weightage="100" keywordseo="Genetic">genetic</keyword> screening of newborns is rarely done in the country at a macro level. But here is one Mumbai-based start-up that has doing it for over a year now. <keyword id="2024246" type="UNKNOWN" weightage="100" keywordseo="Navigene">Navigene</keyword> has developed a unique and <keyword id="2024273" type="UNKNOWN" weightage="100" keywordseo="Non-invasive-preventive-genetic-screening">non-invasive preventive genetic screening</keyword> service for newborns and adults, which can be implemented at a mass scale. Its primary focus is <keyword id="2024274" type="UNKNOWN" weightage="100" keywordseo="Non-invasive-preventive-testing">non-invasive preventive testing</keyword> including <keyword id="2024278" type="UNKNOWN" weightage="100" keywordseo="Newborn-genetic-screening">newborn genetic screening</keyword>, <keyword id="2024275" type="UNKNOWN" weightage="100" keywordseo="Metabolic-fingerprinting">metabolic fingerprinting</keyword>, <keyword id="2024279" type="UNKNOWN" weightage="100" keywordseo="Prenatal-screening">prenatal screening</keyword> and more, besides offering <keyword id="2024280" type="UNKNOWN" weightage="100" keywordseo="Diagnostic-testing">diagnostic testing</keyword> (<keyword id="2024281" type="UNKNOWN" weightage="100" keywordseo="Cytogenetics">cytogenetics</keyword> &amp; <keyword id="1284857" type="ORGANIZATION" weightage="100" keywordseo="Molecular-Genetics">molecular genetics</keyword>). <keyword id="2024283" type="UNKNOWN" weightage="100" keywordseo="Navigene-Baby-Screen">Navigene Baby Screen</keyword>, the start-up’s flagship product, screens the newborns for 110 genetic and metabolic disorders on the very 3rd day after birth and the company claims it is one of the most comprehensive screening tests in the world. Here is a snapshot that captures the start-up’s operations, vision and viability. 
 
Who runs Navigene (navigene.in): Two co-founders – Dr <keyword id="2024250" type="UNKNOWN" weightage="100" keywordseo="Rishi-Dixit">Rishi Dixit</keyword> (MD &amp; CEO) and Dr <keyword id="1888201" type="PERSON" weightage="100" keywordseo="Vrushali-Joshi">Vrushali Joshi</keyword> (CTO) – and the early-stage incubation and <keyword id="6357097" type="COMPANY" weightage="80" keywordseo="venture-capital">venture capital</keyword> firm, <keyword id="720080" type="COMPANY" weightage="100" keywordseo="IncuCapital">IncuCapital</keyword>. An MBBS and MBA, Dr Rishi has a deep understanding of the healthcare marketing space and also worked with start-ups. Before starting Navigene, he was head of sales &amp; strategy at a start-up in the similar domain. Prior to that, he was manager, health analytics, with ICICI Prudential Life insurance. Dr Vrushali holds a Ph.D. from Mumbai University and is a leading geneticist with more that 15 years of experience. She is also a government-certified genetic counsellor. 
 Navigene was set up by the two co-founders in April 2012, along with IncuCapital’s senior venture partners’ team of <keyword id="2024248" type="UNKNOWN" weightage="100" keywordseo="Surojit-Nandy">Surojit Nandy</keyword>, <keyword id="6393254" type="PERSON" weightage="100" keywordseo="Manish-Kumar">Manish Kumar</keyword> and <keyword id="2024247" type="UNKNOWN" weightage="100" keywordseo="Prashant-Maharaj">Prashant Maharaj</keyword>. The company started operations in November that year. Currently, it boasts a state-of-the-art testing facility and central lab in Mumbai where all samples are flown in from different parts of the country and also from global destinations. This facility also serves as the head office while 2-3 sales people are assigned to each location. Weekly sales meetings are generally held at local CCDs – a good example of asset-light sales offices. 
 But going forward, the start-up plans to open sales offices in Delhi, Bangalore and Hyderabad – small facilities for operational and logistics management. As sample collection is generally done by the people themselves or the <keyword id="6355907" type="UNKNOWN" weightage="100" keywordseo="Medical-facilities">medical facilities</keyword>, the Navigene staff simply picks them up from homes/hospitals and courier them to the HO in Mumbai. 
 
What inspired the venture: The knowledge that non-traditional, highly accurate and revolutionary ways of medical diagnosis is possible through genetic screening and diagnostic techniques. Navigene was founded to bring these advanced <keyword id="684042" type="TECHNOLOGY" weightage="100" keywordseo="medical-technologies">medical technologies</keyword> to India. 
 
What’s the pitch: Early and accurate prediction/diagnosis of disorders and ailments in newborns and adults, through <keyword id="2024271" type="UNKNOWN" weightage="100" keywordseo="Preventive-genetic-screening">preventive genetic screening</keyword> – so that every individual has the opportunity to manage his/her health. “Over the years, we have learnt a great deal about how genes function and how they can cause certain problems. Now is the time to use that knowledge in exciting new ways to prevent and treat <keyword id="6377700" type="UNKNOWN" weightage="100" keywordseo="health-problems">health problems</keyword>,” says Dr Rishi. 
 
How it works: Navigene currently caters to the B2B segment – <keyword id="796241" type="UNKNOWN" weightage="100" keywordseo="corporate-hospitals">corporate hospitals</keyword>, high-end nursing homes with birthing facilities, NICUs (<keyword id="1145483" type="UNKNOWN" weightage="100" keywordseo="neonatal-intensive-care-units">neonatal intensive care units</keyword>) and state-of-the-art <keyword id="2024290" type="UNKNOWN" weightage="100" keywordseo="Paediatric-facilities">paediatric facilities</keyword>. It also works with individual obstetricians/gynaecologists and paediatricians. The start-up typically approaches medical facilities who, in turn, offer/recommend these services to their clients. Once a client registers for the tests, he/she is given the sample collection kit and the rest of the testing procedure follows. 
 
As for newborn screening, parents get the kit as soon as they register and after the birth of the baby, either the hospital staff or the parents collect the urine sample of the baby on the 3rd day. It is then sent Navigene’s central lab in Mumbai where the sample is analysed and reports are sent within 4 days. If the report detects any abnormality, the concerned doctor/hospital/parents are immediately informed and further consultation could be arranged with medical experts. Genetic counselling for the parents is also offered in such cases. 
 
Show me the money: As of now, the start-up has a B2B revenue model in place while the B2C space is essentially serviced through its partners who can reach out to more people. Navigene charges fee per sample testing and its flagship solution, Navigene Baby Screen (NBS), which tests urine sample for 110 disorders, costs Rs 5,000. But to make it more affordable for Tier II cities and smaller medical facilities, customised packages start from Rs 900 for tracking 3-4 basic disorders and can go up to Rs 2,700 for screening 31 commonest disorders that affect infants in the first few months. The company has also tied up with a leading stem cell company for instant access to a large B2C market. “Plus, we want to work with the state governments when they start running the NBS programme at the state-run hospitals, but we will keep the packages small,” says Dr Rishi. 
 
The market size is also huge as around 30 million babies are born in India every year. “As of now, we are targeting 40 cities in India where our addressable market (a fraction of the urban population in these cities) is around 30 lakh babies a year. We aim to cover most of them over the next 3 years through our proprietary sales channel,” adds Dr Rishi. 
 
Claim to fame: A value driver in a critical industry while expansion is its forte. Navigene is a pioneer of sorts, bringing crucial preventive health screening for newborn babies at an affordable price. The start-up is currently doing 500 samples a month and targeting 10,000 samples in the next 3 years. 
 Navigene raised an undisclosed seed round with the help of its institutional co-promoter IncuCapital in August 2012 and it will be raising Series A <keyword id="6357455" type="EVENT" weightage="100" keywordseo="Funding">funding</keyword> in the next 2-3 months. The money will be utilised to grow its presence pan-India and also in other geographies such as South-east Asia and <keyword id="48890" type="COUNTRY" weightage="80" keywordseo="Latin-America">Latin America</keyword>. “We can’t disclose the names just now, but these would be all bigger and more developed countries. We are also talking to a few players in Latin America, which can lead to substantial global expansion,” says Surojit Nandy of IncuCapital. As for pan-India expansion, the company plans to reach 40 cities in next the 3 years through its own B2B sales force. 
 The start-up has hit <keyword id="2024302" type="UNKNOWN" weightage="100" keywordseo="Operational-breakeven">operational breakeven</keyword> in December 2013, within 11 months from starting its sales operations. But it is not really looking at that as a landmark. “We don’t intend to remain operationally cash-positive as we are growing at a breakneck speed and want to keep investing in the growth. That’s the reason we are looking at the Series A funding soon,” says Dr Rishi. 
 “We are also working on some breakthrough <keyword id="2024304" type="UNKNOWN" weightage="100" keywordseo="Screening-products">screening products</keyword> around <keyword id="350054" type="TECHNOLOGY" weightage="100" keywordseo="metabolomics">metabolomics</keyword> in areas like oral &amp; <keyword id="16070" type="ORGANIZATION" weightage="80" keywordseo="breast-cancer">breast cancer</keyword>, and adult metabolic disorders. So a big chunk of the Series A money will be used for product development. We will <keyword id="47916" type="UNKNOWN" weightage="80" keywordseo="invest">invest</keyword> a good amount in Capex and Opex to further strengthen our testing portfolio,” he adds. 
 
Biggest challenge: According to Dr Rishi, there’s no real competition here as very few companies in India focus on genetics (metabolomics). As for the newborn screening business, a few labs who do screening through blood sample testing could be competitors, but they use an entirely different technology platform and can track a maximum of 45 disorders. However, creating awareness among prospective clients is currently the biggest challenge. <keyword id="1912844" type="UNKNOWN" weightage="100" keywordseo="patient-education">Patient education</keyword> is virtually non-existent in India while the cost of reaching them at a micro level could be huge. “That’s why we are opting for online registrations, which will reduce operational costs,” he notes. “Then there are other screening products we are working on. When they hit the market, we should be way ahead of others,” concludes Dr Rishi.

This Start-up Provides Genetic Screening For
Newborns, Adults; To Raise Series A Funding In 2-3 Months

<ul class="summary-list"><li><keyword id="11213212" type="UNKNOWN" weightage="60" keywordseo="bitski">Bitski</keyword> is an <keyword id="4668945" type="PERSON" weightage="60" keywordseo="nft">NFT</keyword> platform that aims to simplify creating, buying, and selling non-fungible tokens. </li><li>The platform closed a Series A funding round led by <keyword id="508487" type="PERSON" weightage="60" keywordseo="Andreessen-Horowitz">Andreessen Horowitz</keyword>. </li><li>Jay-Z and Serena Williams were also investors. </li></ul>An <a href="https://www.businessinsider.com/non-fungible-tokens-nfts-have-taken-over-heres-why-theyre-important-2021-4?utm_source=markets&amp;utm_medium=ingestgest">NFT</a> platform that's branding itself as the "Shopify for NFTs" raised $19 million in Series A funding from investors including Andreessen Horowitz (a16z) and Jay-Z. <a href="https://www.businessinsider.com/nft-startups-non-fungible-tokens-the-art-world-2021-3">Bitski</a> is an NFT marketplace that aims to enable brands to easily create and sell non-fungible tokens through its platforms. Its website encourages content creators to "jump in, zero blockchain experience required," and allows users to purchase digital art with credit cards. A16z's Sriram Krishnan said the venture firm led the Series A funding round and he will be joining the Bitski board."We have a number of investments focusing on NFTs and the metaverse - from Dapper Labs to OpenSea. It only stands to reason we invest in the infrastructure that makes NFTs accessible," Krishnan said in a<a href="https://a16z.com/2021/05/06/investing-in-bitski/"> blog post</a>. Other investors in the funding round include MrBeast's Night Media, and Ari Emanuel, Endeavor CEO. Galaxy Digital, Winklevoss Capital, and Coinbase Ventures participated in a $1.81 million seed funding round in November 2019 for Bitski. The popularity of non-fungible tokens has boomed in 2020, though some warn that a bubble is forming and ready to burst, particularly in the<a href="https://markets.businessinsider.com/news/stocks/nft-art-market-rapid-growth-slowdown-non-fungible-tokens-2021-4-1030371073"> market for NFT art.</a>

Jay-Z and Andreessen Horowitz back a $19 million investment in NFT platform Bitski

After completing its second round of angel <keyword id="6357455" type="EVENT" weightage="100" keywordseo="Funding">funding</keyword>, <keyword id="2947742" type="UNKNOWN" weightage="100" keywordseo="Satvacart">Satvacart</keyword> is in talks with PE funds and venture capitalists to raise USD 10 million (around Rs 65 crore). 
 The Gurgaon based <keyword id="1640900" type="UNKNOWN" weightage="100" keywordseo="Online-grocery">online grocery</keyword> startup will use the Series A funding for geographic expansion. "We are extremely happy with the closure of angel round 2, which involved our old <keyword id="6359051" type="COMPANY" weightage="100" keywordseo="investors">investors</keyword> as well as HNIs as new investors. In times when there are talks of funding getting dried up, second angel funding highlights the confidence of investors in Satvacart's business model," Satvacart founder and CEO Rahul Hari said in a statement. 
 
 
"The Series A funding, to be raised shortly, will be used for geographical expansion. We are on track with our business mantra - Controlled expansion with eye on profitability through operational excellence resulting in high customer satisfaction," he said. 
 
With a range of over 4,000 products and a customer base of more than 5,000 in Gurgaon, it is planning to expand its operations to other parts of Delhi-NCR shortly. 
 
(Image credits: )

Online grocery startup in talks to raise USD 10 million

App SamuraiApp Samurai leadership team (left to right): Soner Sensoy, Selin Eze, Seyhmus Olker, Mehmet Bilgin, Emre Fadillioglu<ul class="summary-list"><li>The startup behind App Samurai, an in-app marketing tool for developers, has raised $2.4 million in a Series A funding round. </li><li>App Samurai opened offices in the US, Germany and Israel last week - and plans to use the new money to boost its global presence. </li><li>We got an exclusive look at the pitch deck that convinced backers at 212 Ventures and Collective Spark to invest. </li><li><a href="https://www.businessinsider.com/?hprecirc-bullet">Visit Business Insider's homepage for more stories</a>.</li></ul>App Samurai, a platform for marketing mobile apps, closed a $2.4 million Series A fundraising round last week, after being backed by 212 Ventures. The startup, founded in 2016, offers app developers access to its portfolio of products, which includes Interceptd, a fraud-prevention service, and Storyly, which allow users to deploy in-app stories, similar to Facebook or Snapchat.App Samurai currently operates across nine cities globally, and last year opened offices in the US, Germany and Israel. CEO and co-founder Emre Fadillioglu said the new fundraising money would be used to boost App Samurai's global presence. App SamuraiApp Samurai CEO and co-founder Emre Fadillioglu"Our team's curiosity and ambitious engineering culture are the main drivers of our growth as an independent and unbiased leader in mobile marketing and ad fraud prevention," he said.Ali H Karabey, co-founder and partner at 212 Ventures, added: "App Samurai's product portfolio is designed to simplify sophisticated mobile marketing problems."The company's dedication to scalable martech solutions, for which the market has an appetite, will drive their success."Here's a look at App Samurai's (redacted) pitch deck:

You Searched For "Series A funding" and got 8 results

InsuranceDekho raises $150 mn, largest-ever Series A funding by an insuretech startup

IANS

Agri-tech startup Ecozen raises USD 6mn in Series A funding

PTI

Payment solutions company Twid raises $12 million in series A funding from Rakuten Capital, Google and others

Vaamanaa Sethi

Skincare brand Minimalist raises ₹110 crore in Series A funding led by Sequoia Capital India

IANS

This Start-up Provides Genetic Screening For Newborns, Adults; To Raise Series A Funding In 2-3 Months

Sanghamitra Mandal

Jay-Z and Andreessen Horowitz back a $19 million investment in NFT platform Bitski

Emily Graffeo

Online grocery startup in talks to raise USD 10 million

BI India Bureau

We got an exclusive look at the pitch deck mobile ad startup App Samurai used to raise millions for its Series A funding round

Martin Coulter

Popular Keywords

Buying Guides